Prime Stock update: Book Profits on this pharma player

Find out why it’s time to lock into your gains on this pharma stock.

This article is available for Prime register users only

To read the full article

prime stocks, stocks

N V Chandrachoodamani

Chandrachoodamani started his capital market career in mid 2000s with Equity Intelligence India and then worked with several capital market Intermediaries in various roles over the last 15 years. Most of his career experience has been in equity research and PMS. Most recently, he was with MOAT, a PMS firm. He is a graduate in mathematics, a post graduate in finance, and holds a CFP certification. LinkedIn|Twitter

All Posts »